Photo by GeoJango Maps on Unsplash
When expanding your international business in the derma and aesthetic medicine sector, it is crucial to anticipate potential challenges that could disrupt market operations. The risks are significantly higher if your business is based in only one or two countries. Therefore, we recommend broadening your activities to at least 5-7 markets in different regions, as well as 3-4 indication groups.
Dependance on one or two countries only, is risky
The dependence on a limited number of countries poses significant risks. Such limited market exposure makes your business highly vulnerable to fluctuations and crises specific to those markets. Any adverse event, such as political instability, economic downturns, or regulatory changes, could severely impact your operations and profitability. Diversifying your market presence is essential to mitigate these risks and ensure operational resilience and long-term sustainability in the dynamic aesthetic medicine and derma industry.
Expanding your Derma & Aesthetic Medicine Business Internationally
To mitigate the risks of overdependence on a single market, consider expanding your business internationally. We recommend targeting at least 50%, ideally 70-80%, of your operations in 5 to 7 countries and across 3 to 4 indication segments. Diversifying your market presence not only reduces the likelihood of operational disruptions but also enhances your portfolio by broadening your global reach.
Figure 1. CPC Group: Expanding your Derma and Aesthetic Medicine business internationally
Which countries to consider for Derma and Aesthetic Medicine expansion?
The world offers vast opportunities for international operations, and certain regions present particularly compelling prospects. Here are a few regions worth considering:
LATAM
Latin America boasts several promising emerging OTC and Pharma countries with solid growth in the aesthetic medicine sector, supported by favorable regulations. Dynamic markets in countries such as Mexico, Colombia and Brazil present significant opportunities for expansion.
Asia
Asia presents immense potential in the aesthetic medicine sector due to its high economic growth, burgeoning middle class with rising disposable income, aging population, and ongoing government reforms. Countries such as China, South Korea, Indonesia, and the Philippines offer attractive opportunities for expansion, depending on your portfolio and strategic goals.
Europe
While Europe encompasses numerous mature markets, it continues to offer lucrative prospects in the aesthetic medicine sector. Countries such as France, Germany, the United Kingdom, Italy, Spain, the Nordic Region, Benelux, and Poland are at the forefront of the European aesthetic medicine market, presenting excellent opportunities for expansion and growth.
Figure 2. CPC Group: Potential regions to expand your Derma and Aesthetic Medicine business internationally
Reaching Market Independence with CPC Group
Chameleon Pharma Consulting Group (CPC) has more than 20 years of experience in supporting Pharma, OTC, Medical Devices, Phyto, and Aesthetic Medicine companies. Having established own offices & local hubs across Latin America, Europe, Asia, the US/Canada, the Middle East, and the CEE/CIS regions is another advantage of CPC. With this local network and expertise gained from 300+ international projects and a team of 25 experts we offer our clients:
- Business Development, M&A, and Due Diligence
- Market Entry & Expansion: Systematic product and country analysis, market reports
- Strategic Partnering: Identifying local partners, acquisitions, or setting up own offices
- Regulatory & Registration: for drugs, MD, Derma, Aesthetic Medicine, etc.
- Market Authorization & Compliance: Holding MAs, conducting pharmacovigilance
- Quality & Certification: GMP certification, pre-GMP audits
Contact us today for your individual request at service@chameleon-pharma.com!
